Search Results - "Models, Economic [MeSH]"

Modelling Alternative Economic Incentive Schemes for Semi-Natural Grassland Conservation in Estonia

Authors: Nishizawa, Takamasa Schuler, Johannes Bethwell, Claudia et al.

Source: Environ Manage

Subject Terms: Economic viability, Grassland [MeSH], Integrated land-use modelling, Models, Economic [MeSH], Animals [MeSH], Habitat quality, Biodiversity [MeSH], Agriculture/economics [MeSH], Article, Semi-natural grasslands, Estonia [MeSH], Conservation of Natural Resources/methods [MeSH], Sustainable rural development, Abandonment, Estonia, 0106 biological sciences, Conservation of Natural Resources, 333.7 Landflächen, Naturräume für Freizeit und Erholung, Naturreservate, Energie, ddc:333, Agriculture, Biodiversity, 04 agricultural and veterinary sciences, Grassland, 01 natural sciences, Models, Economic, Animals, 690 Bau von Gebäuden, 0401 agriculture, forestry, and fisheries, ddc:690

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39090440
https://pmc.ncbi.nlm.nih.gov/articles/PMC11393159/
https://repository.publisso.de/resource/frl:6497189
http://edoc.hu-berlin.de/18452/33114
https://doi.org/10.18452/32495

Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment

Authors: Mohsen Ghaffari Darab Lidia Engel Dennis Henzler et al.

Source: Appl Health Econ Health Policy

Subject Terms: ddc:610, Models, Economic, Cost-Benefit Analysis, Systematic Review, Cost-Benefit Analysis [MeSH], Humans [MeSH], Dementia/economics [MeSH], Dementia/therapy [MeSH], Models, Economic [MeSH], Humans, Dementia

Access URL: https://pubmed.ncbi.nlm.nih.gov/38554246
https://hdl.handle.net/10419/315798
https://repository.publisso.de/resource/frl:6507023

The PHEM-B toolbox of methods for incorporating the influences on Behaviour into Public Health Economic Models

Authors: Squires, Hazel Kelly, Michael Gilbert, Nigel et al.

Contributors: Squires, Hazel Kelly, Michael Gilbert, Nigel et al.

Source: BMC Public Health
BMC Public Health, Vol 24, Iss 1, Pp 1-25 (2024)
Squires, H, Kelly, M, Gilbert, N, Sniehotta, F, Purshouse, R, Garcia, L, Breeze, P, Brennan, A, Gardner, B, Bright, S, Fischer, A, Heppenstall, A, Davan Wetton, J, Hernandez-Alava, M, Boyd, J, Buckley, C, Vlaev, I, Smith, R, Abbas, A, Gibb, R, Henney, M, Moore, E & Chater, A 2024, 'The PHEM-B toolbox of methods for incorporating the influences on Behaviour into Public Health Economic Models', BMC Public Health, vol. 24, 2794. https://doi.org/10.1186/s12889-024-20225-1

Subject Terms: economic, Maintenance, Health Behavior, Economic, psychology, Public Health Economic Models, public health interventions, methods, maintenance, Sociology, PHEM-B toolbox, Methods, Diabetes Mellitus, Psychology, Humans, Behaviour, Theory, name=SDG 3 - Good Health and Well-being, theory, sociology, Public health, Research, Health Policy, Complexity, simulation, Humans [MeSH], Models, Economic [MeSH], Health Behavior [MeSH], Simulation, Health Policy [MeSH], Public Health [MeSH], Diabetes Mellitus/prevention, behaviour, Models, Economic, Subject Categories::H123 Public Health Engineering, Public Health, Public aspects of medicine, RA1-1270, complexity

File Description: application/pdf; application/zip; text/xml

Access URL: https://pubmed.ncbi.nlm.nih.gov/39395958
https://doaj.org/article/f26c054fafb14d2bab6db861fe8e091e
https://pure.qub.ac.uk/en/publications/ce2f577b-fd73-4e51-a3fe-a4a8555f9b84
https://repository.publisso.de/resource/frl:6491802
https://www.repository.cam.ac.uk/handle/1810/374893
https://doi.org/10.1186/s12889-024-20225-1

Inclusion of phase III clinical trial costs in health economic evaluations

Authors: Gandjour, Afschin

Source: BMC Health Serv Res
BMC Health Services Research, Vol 24, Iss 1, Pp 1-7 (2024)

Subject Terms: Health-economic evaluations, Models, Economic, Clinical Trials, Phase III as Topic, Modeling, Phase III clinical trial, Research, Cost-effectiveness, Humans [MeSH], Cost-Benefit Analysis/methods [MeSH], Models, Economic [MeSH], Clinical Trials, Phase III as Topic [MeSH], Study protocol, Cost-Benefit Analysis, Humans, Public aspects of medicine, RA1-1270

Access URL: https://pubmed.ncbi.nlm.nih.gov/39354524
https://doaj.org/article/d49684efe6e5458388ce9a31fdd1d8df
https://repository.publisso.de/resource/frl:6504971

Dataset: a social accounting matrix for Germany

Authors: Connolly, Kevin Ross, Andrew Vögele, Stefan

Source: BMC Res Notes
BMC Research Notes, Vol 17, Iss 1, Pp 1-3 (2024)
BMC Research Notes 17(1), 262 (2024). doi:10.1186/s13104-024-06925-2

Subject Terms: Accounting/methods [MeSH], Data Note, Data Notes, Germany [MeSH], Humans [MeSH], Income/statistics, National Accounts, Input-Output, Computable General Equilibrium, Models, Economic [MeSH], Socioeconomic Factors [MeSH], Social Accounting Matrix, Science (General), QH301-705.5, Q1-390, Models, Economic, Socioeconomic Factors, Germany, Accounting, Income, Medicine, Humans, Biology (General), Economic Theory

File Description: text

Access URL: https://pubmed.ncbi.nlm.nih.gov/39267197
https://doaj.org/article/0e1806dc662642beb0da6698a77edab4
https://juser.fz-juelich.de/record/1030938
https://repository.publisso.de/resource/frl:6498395

A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation

Authors: Hansen, Morten Lock Moss, Joe W. E. Tønnesen, Jacob et al.

Source: BMC Cardiovasc Disord
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-10 (2024)

Subject Terms: Cryoablation, Male, Time Factors, Cost-Benefit Analysis, Denmark, Cryosurgery, Drug Costs, Decision Support Techniques, 03 medical and health sciences, 0302 clinical medicine, Atrial Fibrillation, Diseases of the circulatory (Cardiovascular) system, Humans, Randomized Controlled Trials as Topic, Aged, Research, Middle Aged, Atrial fibrillation, Markov Chains, Antiarrhythmic drugs, 3. Good health, Treatment Outcome, Models, Economic, Pulmonary Veins, RC666-701, Quality of Life, Cost-effectiveness, Female, Quality-Adjusted Life Years, Anti-Arrhythmia Agents, Denmark [MeSH], Cost-Benefit Analysis [MeSH], Aged [MeSH], Atrial Fibrillation/diagnosis [MeSH], Atrial Fibrillation/therapy [MeSH], Anti-Arrhythmia Agents/economics [MeSH], Atrial Fibrillation/drug therapy [MeSH], Decision Support Techniques [MeSH], Cryosurgery/economics [MeSH], Randomized Controlled Trials as Topic [MeSH], Drug Costs [MeSH], Quality-Adjusted Life Years [MeSH], Atrial Fibrillation/surgery [MeSH], Decision Trees [MeSH], Male [MeSH], Markov Chains [MeSH], Quality of Life [MeSH], Atrial Fibrillation/economics [MeSH], Cost Savings [MeSH], Female [MeSH], Anti-Arrhythmia Agents/therapeutic use [MeSH], Pulmonary Veins/physiopathology [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Models, Economic [MeSH], Pulmonary Veins/surgery [MeSH], Time Factors [MeSH], Atrial Fibrillation/physiopathology [MeSH], Cryosurgery/adverse effects [MeSH]

Access URL: https://pubmed.ncbi.nlm.nih.gov/39014312
https://doaj.org/article/6541dad1597e4024bf1f01d3ea252d31
https://repository.publisso.de/resource/frl:6519663

How feasible is it to mobilize $31 billion a year for pandemic preparedness and response? An economic growth modelling analysis

Authors: Minahil Shahid Marco Schäferhoff Garrett Brown et al.

Source: Global Health
Globalization and Health, Vol 20, Iss 1, Pp 1-10 (2024)

Subject Terms: Low- and middle-income countries, Research, Gross Domestic Product, Pandemic Preparedness, 1. No poverty, COVID-19, Global Health, 16. Peace & justice, 3. Good health, Pandemic Preparedness [MeSH], Pandemics/economics [MeSH], Humans [MeSH], COVID-19/economics [MeSH], Gross Domestic Product [MeSH], Health Expenditures/statistics, Models, Economic [MeSH], Economic Development [MeSH], Health Expenditures/trends [MeSH], COVID-19/prevention, Pandemic preparedness and response, Global Health [MeSH], COVID-19/epidemiology [MeSH], Developing Countries [MeSH], Health financing, Models, Economic, 8. Economic growth, Humans, Economic Development, Public aspects of medicine, RA1-1270, Health Expenditures, Pandemics, Developing Countries

Access URL: https://pubmed.ncbi.nlm.nih.gov/39030585
https://doaj.org/article/73cc0cabfa084418a9bc0aafb78de5bf
https://repository.publisso.de/resource/frl:6507528

Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review: Results from a Systematic Review

Authors: Clazinus Veijer Marinus H. van Hulst Benjamin Friedrichson et al.

Source: Pharmacoeconomics

Subject Terms: Cost-Benefit Analysis, COVID-19, Systematic Review, Cost-Benefit Analysis [MeSH], Pandemics/economics [MeSH], Humans [MeSH], Severity of Illness Index [MeSH], COVID-19/economics [MeSH], Antiviral Agents/economics [MeSH], Hospitalization/statistics, Models, Economic [MeSH], Decision Support Techniques [MeSH], COVID-19 Drug Treatment [MeSH], Quality-Adjusted Life Years [MeSH], Quality of Life [MeSH], Antiviral Agents/therapeutic use [MeSH], Hospitalization/economics [MeSH], Antiviral Agents, Severity of Illness Index, COVID-19 Drug Treatment, Decision Support Techniques, Hospitalization, 03 medical and health sciences, 0302 clinical medicine, Models, Economic, Quality of Life, Humans, Quality-Adjusted Life Years, 0305 other medical science, Pandemics

Access URL: https://pubmed.ncbi.nlm.nih.gov/38727991
https://research.rug.nl/en/publications/189df5cc-61a5-4d14-9f18-4c1de690ff20
https://hdl.handle.net/11370/189df5cc-61a5-4d14-9f18-4c1de690ff20
https://doi.org/10.1007/s40273-024-01375-x
https://repository.publisso.de/resource/frl:6504453

Modelling Covid-19 under uncertainty: what can we expect?

Authors: Wang, Meimei Flessa, Steffen

Source: Eur J Health Econ
The European Journal of Health Economics

Subject Terms: ddc:610, I100, Models, Statistical, SARS-CoV-2, Health Policy, Economics, Econometrics and Finance (miscellaneous), Decision Making, Pneumonia, Viral, Uncertainty, COVID-19, Pandemics/economics [MeSH], Humans [MeSH], Pneumonia, Viral/economics [MeSH], Models, Economic [MeSH], Editorial, Coronavirus Infections/economics [MeSH], COVID-19 [MeSH], Models, Statistical [MeSH], Betacoronavirus [MeSH], SARS-CoV-2 [MeSH], Decision Making [MeSH], Uncertainty [MeSH], 3. Good health, Betacoronavirus, 03 medical and health sciences, Models, Economic, 0302 clinical medicine, Humans, Coronavirus Infections, Pandemics

Access URL: https://link.springer.com/content/pdf/10.1007/s10198-020-01202-y.pdf
https://pubmed.ncbi.nlm.nih.gov/32494911
https://hdl.handle.net/10419/288477
https://repository.publisso.de/resource/frl:6470618

COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness

Authors: Carl A B Pearson Fiammetta Bozzani Simon R Procter et al.

Source: PLoS Med
PLoS Medicine, Vol 18, Iss 10, p e1003815 (2021)

Subject Terms: 0301 basic medicine, COVID-19 Vaccines, Cost-Benefit Analysis, Population, Vaccine efficacy, Social Sciences, Coronavirus Disease 2019 Research, FOS: Health sciences, Cost effectiveness, Disability-adjusted life year, 03 medical and health sciences, COVID-19, Health Impact Assessment/trends, Health Impact Assessment/economics [MeSH], COVID-19 Vaccines/economics [MeSH], Vaccination/trends, Quality-Adjusted Life Years, General Medicine, Quality-Adjusted Life Years [MeSH], COVID-19 Vaccines/economics, COVID-19/epidemiology [MeSH], Cost-Benefit Analysis/trends, COVID-19 Vaccines/administration, Humans, Vaccination/economics [MeSH], Health Impact Assessment/economics, Pakistan/epidemiology, Vaccination/trends [MeSH], Health Impact Assessment/methods [MeSH], Humans [MeSH], Cost-Benefit Analysis/methods, Cost-Benefit Analysis/methods [MeSH], COVID-19/economics [MeSH], COVID-19/economics, Models, Economic [MeSH], Health Impact Assessment/trends [MeSH], Models, Economic, Health Impact Assessment/methods, COVID-19/prevention, Vaccination/economics, Cost-Benefit Analysis/trends [MeSH], Pakistan/epidemiology [MeSH], COVID-19/epidemiology, Engineering, 0302 clinical medicine, Sociology, Virology, Health Sciences, FOS: Mathematics, Pathology, Risk analysis (engineering), Pakistan, Civil engineering, Demography, Modeling the Dynamics of COVID-19 Pandemic, Vaccination, Economic impact analysis, 1. No poverty, Disease burden, Economic evaluation, FOS: Sociology, 3. Good health, Infectious Diseases, Environmental health, Health, Modeling and Simulation, Physical Sciences, 8. Economic growth, Factors Affecting Vaccine Hesitancy and Acceptance, Medicine, Vaccination Intention, Health Impact Assessment, Mathematics, FOS: Civil engineering, Research Article

Access URL: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003815&type=printable
https://ecommons.aku.edu/cgi/viewcontent.cgi?article=1953&context=pakistan_fhs_mc_chs_chs
https://pubmed.ncbi.nlm.nih.gov/34606520
https://doaj.org/article/5483efc8283b4575ac5bc7800eb4b403
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523052
https://www.ncbi.nlm.nih.gov/pubmed/34606520
https://researchonline.lshtm.ac.uk/id/eprint/4659836/
https://dx.plos.org/10.1371/journal.pmed.1003815
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003815
https://pubmed.ncbi.nlm.nih.gov/34606520/
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/ar/ppmedrxiv-21252338
http://medrxiv.org/cgi/content/short/2021.02.24.21252338
https://researchonline.lshtm.ac.uk/4659836
https://www.medrxiv.org/content/10.1101/2021.02.24.21252338v2
https://repository.publisso.de/resource/frl:6439205